The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

about

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

Item

http://www.wikidata.org/entity/Q55279228

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@en

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@nl

type

Item

label

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@en

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@nl

prefLabel

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@en

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@nl

P1476

The role of intracavitary therapies in the treatment of malignant pleural mesothelioma.

@en

P2093

Alfredo Mussi

http://www.w3.org/2001/XMLSchema#string

Marcello Carlo Ambrogi

http://www.w3.org/2001/XMLSchema#string

Marco Lucchi

http://www.w3.org/2001/XMLSchema#string

Pietro Bertoglio

http://www.w3.org/2001/XMLSchema#string

Vittorio Aprile

http://www.w3.org/2001/XMLSchema#string

P2860

A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.

Antineoplastic activity of povidone-iodine on different mesothelioma cell lines: results of in vitro study.

Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: a feasibility and pharmacokinetic study.

A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.

Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

Photodynamic therapy for lung cancer and malignant pleural mesothelioma.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study.

Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma.

Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.

P304

S293-S297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/JTD.2017.10.165

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29507798

http://www.w3.org/2001/XMLSchema#string

P932

5830563

http://www.w3.org/2001/XMLSchema#string